This is to inform that due to some circumstances beyond the organizer control, "2nd Edition of International Summit on Hematology and Blood Disorders" (Hematology 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at hematology@magnusconference.com or call + 1 (702) 988 2320.
Hematologic malignancies (leukemias and lymphomas) can emerge at any point of the hematopoiesis cascade's differentiation. While visual examination under the microscope can occasionally provide insight into the type of hematologic malignancy, the morphologic appearance is not always adequate to subcategorize the cancer. Hematological malignancies, which include leukaemia, lymphoma, and plasma cell dyscrasia, are malignancies of the blood and blood-forming organs (bone marrow and lymphoid tissues). Every year, millions of adults and children are diagnosed with haematological malignancies such as leukaemia and lymphoma, which are often fatal. Bone marrow transplantation is a well-established treatment for many disorders, with defective blood progenitor cells being replaced with healthy stem cells to achieve cure. Tumors of the hematopoietic and lymphoid tissues and tumours of the haematopoietic and lymphoid tissues affect the blood, bone marrow, lymph, and lymphatic system. Because these tissues are all linked by the circulatory and immunological systems, a sickness that affects one will typically impact the others as well, making myeloproliferation and lymphoproliferation (and consequently leukemias and lymphomas) closely related and frequently overlapping conditions.
Title : Single cell multi-omics in PBMC’s
Peter J Van Der Spek, Erasmus University Medical Center, Netherlands
Title : Myeloid neoplasms and molecular genetic alterations (Germline vs Somatic) that characterize specific entities in pediatric patients
Aida I Richardson, Ann & Robert H. Lurie Children's Hospital of Chicago, United States
Title : Overview of 2021 guidelines on the diagnosis of Von Willebrand Disease (VWD)
Maryam Asif, University of Washington, United States
Title : Clinical management of sickle cell disease
Lambros K Bourantas, Larnaca General Hospital, Cyprus
Title : Clonal evolution in children with inherited bone marrow failure syndromes
Raykina Elena, Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology, Russian Federation
Title : Blood transfusion challenges for one stop perioperative clinic care
Hanadi M Aljedani, King Abdullah Medical City, Saudi Arabia